Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 100,019	$ 99,915
Restricted cash	5,000	0
Marketable securities	826,232	534,216
Trade receivables, net	53,822	0
Inventory	34,068	0
Prepaid expenses and other current assets	13,786	3,150
Total current assets	1,032,927	637,281
Property and equipment, net	2,190	1,553
Intangible assets, net	4,729	0
Right-of-use asset	2,401	1,713
Total assets	1,042,247	640,547
Current liabilities:
Accounts payable	43,599	28,041
Accrued liabilities	124,695	89,980
Lease liability	983	527
Total current liabilities	169,277	118,548
Long term liabilities:
Loan payable, net of discount	117,569	115,480
Lease liability	1,018	1,186
Total long term liabilities	118,587	116,666
Total liabilities	287,864	235,214
Stockholders’ equity:
Preferred stock, par value $0.0001 per share authorized: 5,000,000 shares at December 31, 2024 and December 31, 2023; 2,369,797 and 2,369,797 shares issued and outstanding at December 31, 2024 and December 31, 2023, respectively	0	0
Common stock, par value $0.0001 per share authorized: 200,000,000 at December 31, 2024 and December 31, 2023; 22,004,679 and 19,875,427 shares issued and outstanding at December 31, 2024 and December 31, 2023, respectively	2	2
Additional paid-in-capital	2,556,095	1,741,153
Accumulated other comprehensive income	468	468
Accumulated deficit	(1,802,182)	(1,336,290)
Total stockholders’ equity	754,383	405,333
Total liabilities and stockholders’ equity	$ 1,042,247	$ 640,547